Health Results-Based Financing Impact Evaluation Survey 2010-2011, Baseline
Benin, 2010 - 2011
Get Microdata
Reference ID
BEN_2010_HRBF_v01_M_v01_A_PUF
Producer(s)
Christophe Lemière and Damien de Walque
Collection(s)
Metadata
Created on
Oct 20, 2014
Last modified
Oct 21, 2014
Page views
1012883
Downloads
18717
- Data files
- benhrbf2_d
- benhrbf2_d2_tab21
- benhrbf2_d2_tab22
- benhrbf2_d2_tab25
- benhrbf2_d7_tab71
- benhrbf2_d8_tab811
- benhrbf2_d8_tab812
- benhrbf2_d8_tab813
- benhrbf2_d8_tab814
- benhrbf2_d8_tab815
- benhrbf2_d8_tab816
- benhrbf2_e1_6
- benhrbf2_e1_11
- benhrbf2_e2_q1
- benhrbf2_e2_q20
- benhrbf2_e3_0a
- benhrbf2_e3_0b
- benhrbf2_e3_0c
- benhrbf2_e5_5_6
- benhrbf2_e5_5_7
- benhrbf2_e13_tab_131
- benhrbf2_e13_tab_132
- benhrbf2_e13_tab_133
- benhrbf2_e13_tab_134
- benhrbf2_e13_tab_135
- benhrbf2_e13_tab_139
- benhrbf2_e13_tab_1310
- benhrbf2_f
- benhrbf2_g
- benhrbf2_g1
- benhrbf2_h
- benhrbf2_h6_1
- benhrbf2_h6_2
- benhrbf2_h7
- benhrbf2_h8
- benhrbf2_i
- benhrbf2_i1_tabq26
- benhrbf2_j
- benhrbf2_k
- benhrbf2_k2_1
- benhrbf2_k2_2
- benhrbf2_k2_3_d
- benhrbf2_k3_1
- benhrbf2_k3_2
- benhrbf2_k3_3
- benhrbf2_l
- benhrbf2_l5
- benhrbf2_m
- benhrbf2_n
- benhrbf2_ntab_n5_1
- benhrbf2_ntab_n5_31
- benhrbf2_ntab_n5_61
- benhrbf2_ntab_n6_41
- benhrbf2_ntab_n8_8
- benhrbf2_ntab_n8_10
- benhrbf2_ntab_n8_22
- benhrbf2_ntab_n8_32
- benhrbf2_ntab_n8_53
- benhrbf2_o
- benhrbf2_o6_tabq62
- benhrbf2_o6_tabq64
- benhrbf2_o6_tabq69
- benhrbf2_o6_tabq611
- benhrbf2_p
- benhrbf2_p_7_tabq72
- benhrbf2_p_8
- benhrbf2_p_9
- benhrbf2_p_10
- benhrbf2_q_15b
- benhrbf2_r
- benhrbf2_r_tab_r5_1
- benhrbf2_r_tab_r5_31
- benhrbf2_r_tab_r5_61
- benhrbf2_r_tab_r6_41
- benhrbf2_r_tab_r8_8
- benhrbf2_r_tab_r8_10
- benhrbf2_r_tab_r8_22
- benhrbf2_r_tab_r8_32
- benhrbf2_r_tab_r8_53
- benhrbf2_s
- benhrbf2_s_tab1_3_1
- benhrbf2_s_tab2_13
- benhrbf2_tab_f2_6
- benhrbf2_tab_f2_7
- benhrbf2_tab_f2_8
- benhrbf2_tab_f2_9
- benhrbf2_tab_f2_34
- benhrbf2_tab_f2_35
- benhrbf2_tab_f2_36
- benhrbf2_tab_f2_37
- benhrbf2_tab_f2_38
- benhrbf2_tab_f2_39
- benhrbf2_tab_f2_40
- benhrbf2_tab_f2_41
- benhrbf2_tab_f2_42
- benhrbf2_tab_f3_36b
- benhrbf2_tab_f3_36c
- benhrbf2_tab_f3_42
- benhrbf2_tab_f3_43
- benhrbf2_tab_f3_44
- benhrbf2_tab_f4_1
- benhrbf2_tab_f6
- benhrbf2_tab_f7
- benhrbf2_d_2_tab21_control
- benhrbf2_d_2_tab22_control
- benhrbf2_d_2_tab25_control
- benhrbf2_d_7_tab71_control
- benhrbf2_d_8_tab811_control
- benhrbf2_d_8_tab812_control
- benhrbf2_d_8_tab813_control
- benhrbf2_d_8_tab814_control
- benhrbf2_d_8_tab815_control
- benhrbf2_d_8_tab816_control
- benhrbf2_d_control
- benhrbf2_e1_6_control
- benhrbf2_e1_11_control
- benhrbf2_e2_q1_control
- benhrbf2_e2_q20_control
- benhrbf2_e3_0a_control
- benhrbf2_e3_0b_control
- benhrbf2_e3_0c_control
- benhrbf2_e5_5_6_control
- benhrbf2_e5_5_7_control
- benhrbf2_e13_tab131_control
- benhrbf2_e13_tab132_control
- benhrbf2_e13_tab133_control
- benhrbf2_e13_tab134_control
- benhrbf2_e13_tab135_control
- benhrbf2_e13_tab139_control
- benhrbf2_e13_tab1310_control
- benhrbf2_e_control
- benhrbf2_f_control
- benhrbf2_f_tab2_6_control
- benhrbf2_f_tab2_7_control
- benhrbf2_f_tab2_8_control
- benhrbf2_f_tab2_9_control
- benhrbf2_f_tab2_34_control
- benhrbf2_f_tab2_35_control
- benhrbf2_f_tab2_36_control
- benhrbf2_f_tab2_37_control
- benhrbf2_f_tab2_38_control
- benhrbf2_f_tab2_39_control
- benhrbf2_f_tab2_40_control
- benhrbf2_f_tab2_41_control
- benhrbf2_f_tab2_42_control
- benhrbf2_f_tab3_36b_control
- benhrbf2_f_tab3_36c_control
- benhrbf2_f_tab3_42_control
- benhrbf2_f_tab3_43_control
- benhrbf2_f_tab3_44_control
- benhrbf2_f_tab4_1_control
- benhrbf2_f_tab6_control
- benhrbf2_f_tab7_control
- benhrbf2_g1_control
- benhrbf2_g_control
- benhrbf2_h_6_1_control
- benhrbf2_h_6_2_control
- benhrbf2_h_7_control
- benhrbf2_h_8_control
- benhrbf2_h_control
- benhrbf2_i1_tabq26_control
- benhrbf2_i_control
- benhrbf2_j_control
- benhrbf2_k2_1_control
- benhrbf2_k2_2_control
- benhrbf2_k3_1_control
- benhrbf2_k3_2_control
- benhrbf2_k3_3_control
- benhrbf2_k_control
- benhrbf2_l5_control
- benhrbf2_l_control
- benhrbf2_m_control
- benhrbf2_n_control
- benhrbf2_n_tab5_1_control
- benhrbf2_n_tab5_31_control
- benhrbf2_n_tab5_61_control
- benhrbf2_n_tab6_41_control
- benhrbf2_n_tab8_8_control
- benhrbf2_n_tab8_10_control
- benhrbf2_n_tab8_22_control
- benhrbf2_n_tab8_32_control
- benhrbf2_n_tab8_53_control
- benhrbf_o_6_tabq62_control
- benhrbf_o_6_tabq64_control
- benhrbf_o_6_tabq69_control
- benhrbf_o_6_tabq611_control
- benhrbf_o_control
- benhrbf_p_7_tabq72_control
- benhrbf_p_8_control
- benhrbf_p_9_control
- benhrbf_p_10_control
- benhrbf_p_control
- benhrbf_q_15b_control
- benhrbf_q_15c_control
- benhrbf_q_control
- benhrbf2_r_control
- benhrbf2_r_tab5_1_control
- benhrbf2_r_tab5_31_control
- benhrbf2_r_tab5_61_control
- benhrbf2_r_tab6_41_control
- benhrbf2_r_tab8_8_control
- benhrbf2_r_tab8_10_control
- benhrbf2_r_tab8_22_control
- benhrbf2_r_tab8_32_control
- benhrbf2_r_tab8_53_control
- benhrbf2_s_1_tab31_control
- benhrbf2_s_2_tab13_control
- benhrbf2_s_control
- benHRBF_A-00
- benHRBF_A-01
- benHRBF_A-02
- benHRBF_A-03
- benHRBF_A-04
- benHRBF_A-05
- benHRBF_A-06
- benHRBF_A-07
- benHRBF_A-08
- benHRBF_A-09
- benHRBF_A-10
- benHRBF_A-11
- benHRBF_A-12
- benHRBF_A-13
- benHRBF_B-00
- benHRBF_B-01
- benHRBF_B-02
- benHRBF_B-03
- benHRBF_B-04
- benHRBF_B-05
- benHRBF_B-06
- benHRBF_B-07
- benHRBF_B-08
- benHRBF_B-09
- benHRBF_B-10
- benHRBF_C-00
- benHRBF_C-01
- benHRBF_C-02
- benHRBF_C-03
- benHRBF_C-04
- benHRBF_C-05
- benHRBF_C-06
- benHRBF_A-00_control
- benHRBF_A-01_control
- benHRBF_A-02_control
- benHRBF_A-03_control
- benHRBF_A-04_control
- benHRBF_A-05_control
- benHRBF_A-06_control
- benHRBF_A-07_control
- benHRBF_A-08_control
- benHRBF_A-09_control
- benHRBF_A-10_control
- benHRBF_A-11_control
- benHRBF_A-12_control
- benHRBF_A-13_control
- benHRBF_B-00_control
- benHRBF_B-01_control
- benHRBF_B-02_control
- benHRBF_B-03_control
- benHRBF_B-04_control
- benHRBF_B-05_control
- benHRBF_B-06_control
- benHRBF_B-07_control
- benHRBF_B-08_control
- benHRBF_B-09_control
- benHRBF_B-10_control
- benHRBF_C-00_control
- benHRBF_C-01_control
- benHRBF_C-02_control
- benHRBF_C-03_control
- benHRBF_C-04_control
- benHRBF_C-05_control
- benHRBF_C-06_control
- benhrbf2_e
- benhrbf2_q
- benhrbf_q_control
3.1. designation (j1) (k3_3_1_j1)
Data file: benhrbf2_k3_1_control
Overview
Valid:
168
Invalid:
0
Type:
Discrete
Start:
9
End:
38
Width:
30
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| (MTD) METRONIDAZOLE | 1 |
0.6%
|
|
| ACIDE ACETYLSALICILIQUE | 2 |
1.2%
|
|
| ACIDE ACETYLSALICYLIQUE | 2 |
1.2%
|
|
| ACIDE ACETYLSALICYLIQUE COMPRI | 2 |
1.2%
|
|
| ACIDE FOLIQUE | 2 |
1.2%
|
|
| ACIDEACETYLSALICYLIQUE | 1 |
0.6%
|
|
| ALBENDAZOLE | 1 |
0.6%
|
|
| ALBENDAZOLE COMPRIMES | 1 |
0.6%
|
|
| AMOXICILLINE | 3 |
1.8%
|
|
| AMOXICILLINE COMP | 1 |
0.6%
|
|
| AMOXICILLINE COMPRIMES | 1 |
0.6%
|
|
| AMOXICILLINE SIROP | 4 |
2.4%
|
|
| AMOXICILLINE SUSPENSION | 1 |
0.6%
|
|
| AMOXICILLINE+ACIDE CLAVULANIQU | 1 |
0.6%
|
|
| AMPICILLINE INJEC | 1 |
0.6%
|
|
| ARTHEMETHER LUMEFANTRINE 18CP | 1 |
0.6%
|
|
| ARTHEMETHER LUMEFANTRINE 24CP | 1 |
0.6%
|
|
| ARTHEMETHER LUMEFANTRINE 6CP | 1 |
0.6%
|
|
| ARTHEMETHER-LUMEFANTRINE | 3 |
1.8%
|
|
| ASPEGIC | 1 |
0.6%
|
|
| BANDE ELASTIQUE | 2 |
1.2%
|
|
| BANDE GAZ | 1 |
0.6%
|
|
| BISACODYL COMPRIMES | 1 |
0.6%
|
|
| CATHETER | 1 |
0.6%
|
|
| CIMETIDINE | 1 |
0.6%
|
|
| CIPROFLOXACINE | 4 |
2.4%
|
|
| CIPROFLOXACINE COMPRIMES | 1 |
0.6%
|
|
| CLOXACILINE | 1 |
0.6%
|
|
| CLOXACILLINE COMPRIME | 1 |
0.6%
|
|
| COATERM | 1 |
0.6%
|
|
| COTRIMOXAZOLE | 2 |
1.2%
|
|
| COTRIMOXAZOLE COMPRIME | 1 |
0.6%
|
|
| COTRIMOXAZOLE SIROP | 1 |
0.6%
|
|
| CTA | 1 |
0.6%
|
|
| CTA6 ARTHEMETHER-LUMEFANTRINE | 1 |
0.6%
|
|
| CTM | 2 |
1.2%
|
|
| DIAZEPAM | 3 |
1.8%
|
|
| DIAZEPAM COMPRIMES | 2 |
1.2%
|
|
| DIAZEPAM INJECTABLE | 1 |
0.6%
|
|
| DIAZEPAN | 1 |
0.6%
|
|
| DIAZEPAN INJECTABLE | 1 |
0.6%
|
|
| DOXYCICLINE | 2 |
1.2%
|
|
| DOXYCYCLINE | 1 |
0.6%
|
|
| ERYTHROMICINE | 1 |
0.6%
|
|
| ERYTHROMYCINE COMPRIMES | 1 |
0.6%
|
|
| FER | 7 |
4.2%
|
|
| FER COMPRIME | 1 |
0.6%
|
|
| FER COMPRIMES | 1 |
0.6%
|
|
| FLOXSOL COLLYRE 0.3% | 1 |
0.6%
|
|
| FOLDINE | 6 |
3.6%
|
|
| FOLDINE COMPRIMES | 1 |
0.6%
|
|
| FUMARATE FERREUX | 1 |
0.6%
|
|
| GANTS STERILES | 1 |
0.6%
|
|
| HBB | 3 |
1.8%
|
|
| HBB COMPRIME | 1 |
0.6%
|
|
| HBB COMPRIMES | 1 |
0.6%
|
|
| HBB INJECTABLE | 2 |
1.2%
|
|
| HYCHOCHLOROTHIAZIDE COMPRIMES | 1 |
0.6%
|
|
| HYDROXYDE D'ALLUMINIUM COMPRIM | 1 |
0.6%
|
|
| IBUPROFEN | 1 |
0.6%
|
|
| IBUPROFEN COMPRIME | 1 |
0.6%
|
|
| IBUPROFENE | 2 |
1.2%
|
|
| IBUPROFENE COMPRIMES | 1 |
0.6%
|
|
| INDOCID COMPRIMES | 1 |
0.6%
|
|
| KIT CPN | 1 |
0.6%
|
|
| MEBENDAZOLE | 5 |
3%
|
|
| MEBENDAZOLE COMPRIME | 1 |
0.6%
|
|
| MEBENDAZOLE COMPRIMES | 1 |
0.6%
|
|
| METOCLOPRAMIDE | 2 |
1.2%
|
|
| METRONIDAZOLE | 5 |
3%
|
|
| MICROLUT | 1 |
0.6%
|
|
| MORISTERAT INJECTABLE | 1 |
0.6%
|
|
| MULTIVITAMINE | 3 |
1.8%
|
|
| MULTIVITAMINE COMPRIME | 1 |
0.6%
|
|
| MULTIVITAMINE COMPRIMES | 2 |
1.2%
|
|
| NORISTERAT | 1 |
0.6%
|
|
| NOSCAPINE | 1 |
0.6%
|
|
| NYSTATINE | 1 |
0.6%
|
|
| NYSTATINE ORALE | 1 |
0.6%
|
|
| NYSTATINE OVULE | 1 |
0.6%
|
|
| OCYTOCINE INJECTABLE | 1 |
0.6%
|
|
| ORASEL ZINC | 1 |
0.6%
|
|
| PARACETAMOL | 4 |
2.4%
|
|
| PARACETAMOL COMPRIME | 1 |
0.6%
|
|
| PARACETAMOL COMPRIMES | 2 |
1.2%
|
|
| PARACETAMOL SIROP | 1 |
0.6%
|
|
| PARAFFIZZ | 1 |
0.6%
|
|
| PENICILLINE COMPRIMES | 1 |
0.6%
|
|
| PENICILLINE V | 1 |
0.6%
|
|
| PERFUSEUR | 1 |
0.6%
|
|
| PROMETHAZINE COMPRIMES | 1 |
0.6%
|
|
| QUININE | 5 |
3%
|
|
| QUININE COMPRIME | 1 |
0.6%
|
|
| QUININE COMPRIMES | 2 |
1.2%
|
|
| QUININE INJECTABLE | 1 |
0.6%
|
|
| RANFERON | 1 |
0.6%
|
|
| SALBUTAMOL COMPRIME | 1 |
0.6%
|
|
| SALBUTAMOL COMPRIMES | 1 |
0.6%
|
|
| SERINGUE | 5 |
3%
|
|
| SERUM ANTITETANIQUE | 1 |
0.6%
|
|
| SERUM GLUCOSE 10% | 1 |
0.6%
|
|
| SERUM GLUCOSE 5% | 1 |
0.6%
|
|
| SOLVANT | 1 |
0.6%
|
|
| SPARADRAP | 2 |
1.2%
|
|
| SYNTOCINON AMPOULE | 1 |
0.6%
|
|
| VITAMINE BC INJ | 1 |
0.6%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.